GREY:ATBPF - Post by User
Post by
WalkOverTheStrton Mar 14, 2021 3:14pm
370 Views
Post# 32795496
When will
When will IMO as long as Antibe is on a CA exchange the share price will come no where close to where most biotechs with a PH3 drug are valued ($600M+ minimum of ocurse IMO) let alone one that could reach $4B annual sales....
Dan can talk about waiting for the right time (wind in their sails) but I'd rather have European, USA, Japan, etc. partners signed while on the NASDAQ... market has a short memory and momentum while on the exchange is imperative.
Also any buyout is not going to reach the potential $4B we all hope for unless the stock price is within the typical 60%-100% premium that BoDs approve. No board is going to approve some 200%+ premium, they would be voted out by SHs at next opportunity..
Antibe needs the stock price to appreciate and frankly we are fooling oursleves if we think it will be trading anywhere need there while being on this backwater exchange.